Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Zolpidem Use and Risk of Fracture in Elderly Insomnia Patients

  • Kang, Dong-Yoon (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Park, So-Young (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Rhee, Chul-Woo (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Kim, Ye-Jee (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Choi, Nam-Kyong (Medical Research Collaborating Center, Seoul National University Hospital) ;
  • Lee, Joong-Yub (Medical Research Collaborating Center, Seoul National University Hospital) ;
  • Park, Byung-Joo (Department of Preventive Medicine, Seoul National University College of Medicine)
  • Received : 2011.08.31
  • Accepted : 2011.11.03
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: To evaluate the risk of fractures related with zolpidem in elderly insomnia patients. Methods: Health claims data on the entire South Korean elderly population from January 2005 to June 2006 were extracted from the Health Insurance Review and Assessment Service database. We applied a case-crossover design. Cases were defined as insomnia patients who had a fracture diagnosis. We set the hazard period of 1 day length prior to the fracture date and four control periods of the same length at 5, 10, 15, and 20 weeks prior to the fracture date. Time independent confounding factors such as age, gender, lifestyle, cognitive function level, mobility, socioeconomic status, residential environment, and comorbidity could be controlled using the case-crossover design. Time dependent confounding factors, especially co-medication of patients during the study period, were adjusted by conditional logistic regression analysis. The odds ratios and their 95% confidence intervals (CIs) were estimated for the risk of fracture related to zolpidem. Results: One thousand five hundred and eight cases of fracture were detected in insomnia patients during the study period. In our data, the use of zolpidem increased the risk of fracture significantly (adjusted odds ratio [aOR], 1.72; 95% CI, 1.37 to 2.16). However, the association between benzodiazepine hypnotics and the risk of fracture was not statistically significant (aOR, 1.00; 95% CI, 0.83 to 1.21). Likewise, the results were not statistically significant in stratified analysis with each benzodiazepine generic subgroup. Conclusions: Zolpidem could increase the risk of fracture in elderly insomnia patients. Therefore zolpidem should be prescribed carefully and the elderly should be provided with sufficient patient education.

Keywords

References

  1. Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res 2002;53(1):593-600.
  2. Cho YW, Shin WC, Yun CH, Hong SB, Kim J, Earley CJ. Epidemiology of insomnia in Korean adults: prevalence and associated factors. J Clin Neurol 2009;5(1):20-23.
  3. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004;164(17):1888-1896.
  4. Korean NeuroPsychiatric Association. Textbook of neuropsychiatry. 2nd ed. Seoul: Jungangmunhwa Co.; 2005, p. 670-682 (Korean).
  5. Stone KL, Ensrud KE, Ancoli-Israel S. Sleep, insomnia and falls in elderly patients. Sleep Med 2008;9(Suppl 1):S18-S22.
  6. Maczaj M. Pharmacological treatment of insomnia. Drugs 1993; 45(1):44-55.
  7. Richey SM, Krystal AD. Pharmacological advances in the treatment of insomnia. Curr Pharm Des 2011;17(15):1471-1475.
  8. Lenhart SE, Buysse DJ. Treatment of insomnia in hospitalized patients. Ann Pharmacother 2001;35(11):1449-1457.
  9. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008;9(8):818-822.
  10. King MB. Is there still a role for benzodiazepines in general practice? Br J Gen Pract 1992;42(358):202-205.
  11. Langtry HD, Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990;40(2):291-313.
  12. Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993;12(11):814-828.
  13. Bogan RK. Treatment options for insomnia: pharmacodynamics of zolpidem extended-release to benefit next-day performance. Postgrad Med 2008;120(3):161-171.
  14. Hajak G, Bandelow B. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases. Int Clin Psychopharmacol 1998;13(4):157-167.
  15. Roth T, Roehrs T, Vogel G. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep 1995;18(4):246-251.
  16. Maarek L, Cramer P, Attali P, Coquelin JP, Morselli PL. The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice. J Int Med Res 1992;20(2):162-
  17. Allain H, Monti J. General safety profile of zolpidem: safety in elderly, overdose and rebound effects. Eur Psychiatry 1997; 12(Suppl 1):21-29.
  18. Lee YJ. Overview of the therapeutic management of insomnia with zolpidem. CNS Drugs 2004;18(Suppl 1):17-23.
  19. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004;18(5):297-328.
  20. Mendelson WB. Sleepwalking associated with zolpidem. J Clin Psychopharmacol 1994;14(2):150.
  21. Iruela LM. Zolpidem and sleepwalking. J Clin Psychopharmacol 1995;15(3):223.
  22. Hoque R, Chesson AL Jr. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 2009;5(5):471-476.
  23. Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem--sleepwalking: a case report. Arch Phys Med Rehabil 2005;86(6):1265-1266.
  24. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, et al. Manifestations and management of chronic insomnia in adults. Evid Rep Technol Assess (Summ) 2005;(125): 1-10.
  25. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Sturmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf 2010;19(12):1248-1255.
  26. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331(7526):1169.
  27. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001; 49(12):1685-1690.
  28. Antai-Otong D. The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults. Perspect Psychiatr Care 2006;42(3):196-200.
  29. Ki M. Theory and practice of case-crossover study design. Korean J Epidemiol 2008;30(1):1-11 (Korean).
  30. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133(2):144-153.
  31. Maclure M. 'Why me?' versus 'why now?' Differences between operational hypotheses in case-control versus case-crossover studies. Pharmacoepidemiol Drug Saf 2007;16(8):850-853.
  32. McMahon AD, Evans JM, McGilchrist MM, McDevitt DG, Mac- Donald TM. Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology. Pharmacoepidemiol Drug Saf 1998;7(4):275-280.
  33. Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003;348(1):42-49.
  34. Frost M, Abrahamsen B, Masud T, Brixen K. Risk factors for fracture in elderly men: a population-based prospective study. Osteoporos Int 2012;23(2):521-531.
  35. Hong GR, Cho SH, Tak Y. Falls among Koreans 45 years of age and older: incidence and risk factors. J Adv Nurs 2010;66(9): 2014-2024.
  36. Chang CM, Chen MJ, Tsai CY, Ho LH, Hsieh HL, Chau YL, et al. Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study. Int J Geriatr Psychiatry 2011;26(6):602-607.
  37. Vitry AI, Hoile AP, Gilbert AL, Esterman A, Luszcz MA. The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people. Arch Gerontol Geriatr 2010;50(3):e1-e4.
  38. Richey SM, Krystal AD. Pharmacological advances in the treatment of insomnia. Curr Pharm Des 2011;17(15):1471-1475.
  39. Wagner J, Wagner ML, Hening WA. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 1998;32(6):680-691.
  40. Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LT. Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study. Br J Clin Pharmacol 2011; 72(3):505-513.

Cited by

  1. In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving vol.9, pp.2, 2012, https://doi.org/10.1007/s13181-013-0294-y
  2. Treatment of Insomnia in Older Adults: Re-Evaluating the Benefits and Risks of Sedative Hypnotic Agents vol.39, pp.4, 2013, https://doi.org/10.3928/00989134-20130220-99
  3. Zolpidem, Is it a Safe Drug for Insomnia Management? vol.84, pp.6, 2012, https://doi.org/10.3904/kjm.2013.84.6.802
  4. Association between use of benzodiazepines and risk of fractures: a meta-analysis vol.25, pp.1, 2012, https://doi.org/10.1007/s00198-013-2446-y
  5. Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem? vol.7, pp.1, 2012, https://doi.org/10.1586/17512433.2014.864949
  6. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study vol.70, pp.7, 2012, https://doi.org/10.1007/s00228-014-1684-z
  7. An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population : A Population-Based Case-Control Study vol.94, pp.17, 2012, https://doi.org/10.1097/md.0000000000000809
  8. Care Needs and Clinical Outcomes of Older People with Dementia: A Population-Based Propensity Score-Matched Cohort Study vol.10, pp.5, 2012, https://doi.org/10.1371/journal.pone.0124973
  9. Risk of Type 2 Diabetes in Patients With Nonapnea Sleep Disorders in Using Different Types of Hypnotics : A Population-Based Retrospective Cohort Study vol.94, pp.38, 2012, https://doi.org/10.1097/md.0000000000001621
  10. Is Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan vol.10, pp.12, 2012, https://doi.org/10.1371/journal.pone.0146030
  11. Zolpidem use and risk of fractures: a systematic review and meta-analysis vol.27, pp.10, 2016, https://doi.org/10.1007/s00198-016-3605-8
  12. Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/8032528
  13. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit vol.5, pp.None, 2012, https://doi.org/10.12688/f1000research.8729.3
  14. Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury vol.39, pp.5, 2012, https://doi.org/10.5665/sleep.5742
  15. Screening Tool for Older Persons’ Appropriate Prescriptions in Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the eld vol.16, pp.9, 2016, https://doi.org/10.1111/ggi.12890
  16. Review of Safety and Efficacy of Sleep Medicines in Older Adults vol.38, pp.11, 2012, https://doi.org/10.1016/j.clinthera.2016.09.010
  17. Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research vol.17, pp.4, 2017, https://doi.org/10.1007/s40268-017-0207-7
  18. Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study vol.41, pp.12, 2018, https://doi.org/10.1248/bpb.b18-00411
  19. Cognitive enhancers associated with decreased risk of injury in patients with dementia: a nationwide cohort study in Taiwan vol.66, pp.3, 2012, https://doi.org/10.1136/jim-2017-000595
  20. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis vol.47, pp.2, 2012, https://doi.org/10.1093/ageing/afx167
  21. Insomnia in Elderly Patients: Recommendations for Pharmacological Management vol.35, pp.9, 2018, https://doi.org/10.1007/s40266-018-0569-8
  22. Effectiveness and safety of fire-needle moxibustion on insomnia : Protocol for a systematic review and meta-analysis vol.98, pp.7, 2012, https://doi.org/10.1097/md.0000000000014509
  23. Evaluation of Dissolution Profile between Original and Generic Products of Zolpidem Tartrate by Microdialysis-HPLC vol.67, pp.2, 2012, https://doi.org/10.1248/cpb.c18-00642
  24. Association between Elimination Half-life of Benzodiazepines and Falls in the Elderly: A Meta-analysis of Observational Studies vol.139, pp.1, 2012, https://doi.org/10.1248/yakushi.18-00156
  25. Twelve-year trend in the use of zolpidem and physicians’ non-compliance with recommended duration: a Korean national health insurance database study vol.75, pp.1, 2012, https://doi.org/10.1007/s00228-018-2563-9
  26. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer’s Disease vol.31, pp.2, 2012, https://doi.org/10.1177/0898264318795567
  27. Treatment of sleep disturbance in older adults vol.49, pp.3, 2012, https://doi.org/10.1002/jppr.1565
  28. An Implementation Guide to Promote Sleep and Reduce Sedative-Hypnotic Initiation for Noncritically Ill Inpatients vol.179, pp.7, 2012, https://doi.org/10.1001/jamainternmed.2019.1196
  29. Insomnia, Benzodiazepine Use, and Falls among Residents in Long-term Care Facilities vol.16, pp.23, 2012, https://doi.org/10.3390/ijerph16234623
  30. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review vol.76, pp.3, 2012, https://doi.org/10.1007/s00228-019-02812-z
  31. Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study vol.43, pp.6, 2020, https://doi.org/10.1248/bpb.b19-00684
  32. Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial vol.43, pp.10, 2020, https://doi.org/10.1093/sleep/zsaa080
  33. Effectiveness of App-Based Yoga of Immortals (YOI) Intervention for Insomnia in Asian Population during Pandemic Restrictions vol.18, pp.11, 2021, https://doi.org/10.3390/ijerph18115706
  34. Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person vol.9, pp.2, 2021, https://doi.org/10.3390/medsci9020031
  35. Effect of Multimorbidity on Fragility Fractures in Community-Dwelling Older Adults: Shimane CoHRE Study vol.10, pp.15, 2021, https://doi.org/10.3390/jcm10153225
  36. Effects of anticholinergic and sedative medication use on fractures: A self‐controlled design study vol.69, pp.11, 2021, https://doi.org/10.1111/jgs.17377
  37. Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database vol.14, pp.12, 2012, https://doi.org/10.3390/ph14121299